Skip to Main Content

Paper Details

How Communicating Polygenic and Clinical Risk for Atherosclerotic Cardiovascular Disease Impacts Health Behavior: an Observational Follow-up Study.
Circulation. Genomic and precision medicine
41
2022
Atherosclerotic Cardiovascular Disease, atherosclerotic cardiovascular disease, participants, persons, polygenic, women
Author NameAffiliation
Elisabeth WidenInstitute for Molecular Medicine Finland, University of Helsinki
Ida SurakkaInstitute for Molecular Medicine Finland, University of Helsinki
Ida SurakkaUniversity of Michigan ann arbor
Tiinamaija TuomiInstitute for Molecular Medicine Finland, University of Helsinki
Tiinamaija TuomiClinical and Molecular Metabolism (T.T.), University of Helsinki
Tiinamaija TuomiFolkhalsan Research Center
Tiinamaija TuomiLund University Diabetes Centre, Lund University
Aarno PalotieInstitute for Molecular Medicine Finland, University of Helsinki
Aarno PalotieMassachusetts General Hospital & Harvard Medical School, Boston & Broad Institute of MIT & Harvard
Veikko SalomaaFinnish Institute for Health and Welfare
Jaakko KaprioInstitute for Molecular Medicine Finland, University of Helsinki
Samuli RipattiInstitute for Molecular Medicine Finland, University of Helsinki
Samuli RipattiClinicum (S.R.), University of Helsinki
Samuli RipattiMassachusetts General Hospital & Harvard Medical School, Boston & Broad Institute of MIT & Harvard
  • 1 - 14

Datasets